Wen‐Hsin Tseng
Papers
3
Total Citations
8
H-Index
2
About
Dr. Wen-Hsin Tseng is a leading urologic surgeon and researcher whose work focuses on advancing surgical outcomes for upper tract urothelial carcinoma (UTUC) and renal tumors, particularly in high-endemic regions like Taiwan. Her major contributions include landmark studies on segmental ureterectomy for UTUC, where she led a nationwide collaborative effort demonstrating that this nephron-sparing approach offers a viable alternative to radical nephrectomy for selected patients, directly informing clinical guidelines in endemic areas. Dr. Tseng has also pioneered the use of indocyanine green (ICG) fluorescence-guided embolization during robot-assisted partial nephrectomy, developing a novel retroperitoneal approach that enhances precision in treating totally endophytic renal masses. Her comparative outcomes research on retroperitoneal partial nephrectomy for cT1 and cT2 renal tumors has further established the safety and efficacy of this technique for larger tumors, expanding surgical options. With her most-cited papers accumulating over 8 citations in just two years, Dr. Tseng’s work is rapidly shaping urologic oncology practice, offering patients less invasive, kidney-sparing treatments while setting new standards for surgical innovation in endemic disease settings.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3